interest group

Sales & Marketing

Partner Content

Your industry needs you for the PM Society Diversity, Equity, and Inclusion Interest Group benchmarking survey 2024.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.